Skip to main content

Research Repository

Advanced Search

Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals

Mitchell, Eleanor; Goodman, Kirsteen; Hartley, Suzanne; Hickey, Helen; McDonald, Alison M.; Meadows, Helen M.; Rhodes, Shelley; Taylor, Jodi; Wakefield, Natalie; Farrell, Barbara; UK Trial Managers� Network Executive Group

Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals Thumbnail


Authors

Kirsteen Goodman

Suzanne Hartley

Helen Hickey

Alison M. McDonald

Helen M. Meadows

Shelley Rhodes

Jodi Taylor

Natalie Wakefield

Barbara Farrell

UK Trial Managers� Network Executive Group



Abstract

Background
Clinical trials commonly have a dedicated trial manager and effective trial management is essential to the successful delivery of high-quality trials. Trial managers have diverse experience and currently there is no standardised structured career pathway. The UK Trial Managers’ Network (UKTMN) surveyed its members to understand what is important to them with respect to career development since this would be important in the development of any initiative intended to develop a skilled workforce.

Methods
We conducted an online survey of UKTMN members, who are trial management professionals, working on academic-led trials in the UK. Members were asked what they perceive as opportunities and barriers to career development. Two reminders were sent to facilitate completion of the survey, and responders were offered the opportunity to enter a prize draw for waived fees at the UKTMN annual meeting. Data were analysed descriptively by using Stata (version 15.1), and free-text responses were reviewed for themes.

Results
The survey was sent to 819 UKTMN members; 433 responses were received, although 13 were from non-UKTMN members; thus 420 respondents' data were included in analyses. Respondents were representative of UKTMN membership; however, more responses were received by trial managers based in registered clinical trials units (CTUs). The top three opportunities for career development were (i) training, (ii) helping design trials and (iii) undertaking relevant qualifications. The top three barriers were (i) funding, (ii) few opportunities to get involved in development activities aside from managing a trial and (iii) unclear organisational career pathway. Almost all respondents (401/420, 95.4%) considered career development either very or quite important. Although all respondents had a day-to-day role in managing trials, there was huge disparity between job titles.

Conclusion
Career development is important to trial managers yet there is a lack of a structured pathway. The enablers and disablers to career development for trial managers should be clearly considered by the clinical trial community and, in particular, employers, sponsors and funders in order to develop a highly skilled workforce of trial managers, who are key to the delivery of trials.

Citation

Mitchell, E., Goodman, K., Hartley, S., Hickey, H., McDonald, A. M., Meadows, H. M., Rhodes, S., Taylor, J., Wakefield, N., Farrell, B., & UK Trial Managers’ Network Executive Group. (2020). Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals. Trials, 21, Article 384. https://doi.org/10.1186/s13063-020-04316-z

Journal Article Type Article
Acceptance Date Apr 10, 2020
Online Publication Date May 6, 2020
Publication Date May 6, 2020
Deposit Date May 13, 2020
Publicly Available Date May 18, 2020
Journal Trials
Electronic ISSN 1745-6215
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 21
Article Number 384
DOI https://doi.org/10.1186/s13063-020-04316-z
Keywords Clinical trial, Trial management, Trial manager, Career development, Survey, UKTMN, Project management
Public URL https://nottingham-repository.worktribe.com/output/4292492
Publisher URL https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04316-z